This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: Applied Genetic Technologies Corporation. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: David R. Knop: Innovator in Gene Therapy
Introduction
David R. Knop is a notable inventor based in Gainesville, FL (US). He has made significant contributions to the field of gene therapy, particularly through his innovative methods for producing recombinant viral particles. His work is essential for advancing therapeutic techniques that can improve patient outcomes.
Latest Patents
David R. Knop holds a patent for "Recombinant virus production using mammalian cells in suspension." This invention provides methods for producing recombinant AAV viral particles using cells grown in suspension. The recombinant AAV particles developed through this method are crucial for delivering genes that encode therapeutic proteins, thereby enhancing gene therapy applications.
Career Highlights
David is associated with Applied Genetic Technologies Corporation, where he applies his expertise in genetic engineering and viral vector development. His work at the company has positioned him as a key player in the advancement of gene therapy technologies.
Collaborations
David has collaborated with notable colleagues, including Darby Thomas and Gabor Veres. These partnerships have fostered innovation and contributed to the success of their projects in the field of gene therapy.
Conclusion
David R. Knop's contributions to the field of gene therapy through his innovative patent and collaborative efforts highlight his importance as an inventor. His work continues to pave the way for advancements in therapeutic techniques that can benefit many patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile